Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-17 of 17
Keywords: Androgen deprivation therapy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Further Areas
Bernd J. Schmitz-Dräger, Ekkehardt Bismarck, Thomas Ebert, Roland Starlinger, Kerstin Dienes, Bertram Ottillinger, Peter J. Goebell, Stephan Mühlich, Natalya Benderska-Söder, Jutta Bergler-Klein, Oliver W. Hakenberg
Journal:
Urologia Internationalis
Urol Int (2025)
Published Online: 20 February 2025
... study in patients with locally advanced and metastatic hormone-sensitive prostate cancer (PC). This analysis explores the efficacy and safety of leuprorelin in patients with PC and an indication for androgen deprivation therapy (ADT) in routine practice. Methods: Safety assessment focused...
Journal Articles
Preliminary Efficacy, Tolerability, and Safety Analysis of Darolutamide for Metastatic Castration-Resistant Prostate Cancer: A Single-Center, Open-Label Study
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2025) 109 (2): 167–174.
Published Online: 15 October 2024
... prostate cancer (mHSPC). The aim was to assess the efficacy and safety of Darolutamide for mCRPC. Methods: In this single-center, open-label study, patients with previously untreated mCRPC were enrolled and received androgen deprivation therapy (goserelin acetate 3.6 mg every 28 days) and docetaxel (75 mg...
Journal Articles
Comparing Efficacies of Different Exercises on Androgen Deprivation Therapy Adverse Effects in Prostate Cancer Patients: A Network Meta-Analysis
Available to PurchaseSubject Area:
Further Areas
Siping Hu, Xingyu Xiong, Shi Qiu, Jiakun Li, Hang Xu, Xianghong Zhou, Sheng Wang, Qiang Wei, Lu Yang
Journal:
Urologia Internationalis
Urol Int (2024) 108 (4): 298–313.
Published Online: 02 March 2024
...Siping Hu; Xingyu Xiong; Shi Qiu; Jiakun Li; Hang Xu; Xianghong Zhou; Sheng Wang; Qiang Wei; Lu Yang Introduction: Previous studies showed exercise have efficacies for androgen deprivation therapy (ADT) adverse effects. To compare the efficacies of different exercises on ADT adverse effects, we...
Journal Articles
Journal:
Urologia Internationalis
Urol Int (2023) 107 (6): 624–631.
Published Online: 13 June 2023
...Sangjun Yoo; Kyung Hee Lee; Parivash Jamrasi; Min Chul Cho; Wook Song; Hyeon Jeong Introduction: We assessed the effects of exercise on the physical function and health quality of life (hQoL) in prostate cancer patients underwent androgen deprivation therapy (ADT). Additionally, the effects of high...
Journal Articles
Subject Area:
Further Areas
Bernd J. Schmitz-Dräger, Stephan Mühlich, Carsten Lange, Natalya Benderska-Söder, Ekkehardt Bismarck, Roland Starlinger, Bertram Ottillinger, Oliver W. Hakenberg
Journal:
Urologia Internationalis
Urol Int (2021) 105 (5-6): 436–445.
Published Online: 25 February 2021
... implant in patients with prostate cancer (PCa) in a real-world setting. Methods: 959 PCa patients scheduled for androgen deprivation therapy (ADT) received leuprorelin acetate implant. Metabolism, serum prostate-specific antigen (PSA), and testosterone data, if available, were collected at baseline...
Journal Articles
Impact of Androgen Deprivation Therapy on Non-Alcoholic Fatty Liver Disease in Patients with Prostate Cancer: A CT Evaluation
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2020) 104 (5-6): 425–430.
Published Online: 12 May 2020
...Harutake Sawazaki; Yosuke Kitamura; Kota Yagi; Yuichi Arai Purpose: The aim of this study was to investigate the influence of androgen deprivation therapy (ADT) on the progression of non-alcoholic fatty liver disease (NAFLD) in patients with prostate cancer (PCa) by evaluation of hepatic steatosis...
Journal Articles
Androgen Deprivation Therapy and the Risk of Stroke in Patients with Prostate Cancer: An Updated Systematic Review and Meta-Analysis
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2020) 104 (3-4): 214–221.
Published Online: 20 November 2019
...Ranlu Liu; Jiatong Zhou; Shuai Xia; Tao Li Background: The aim of this article was to review the association between androgen deprivation therapy (ADT) and the risk of stroke in patients with prostate cancer (PC). Thus, we performed this study to understand the impact of ADT on the incidence...
Journal Articles
Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2018) 100 (3): 251–262.
Published Online: 21 November 2017
... recurrence. Adjuvant therapy for radical prostatectomy (RP) or local radiotherapy (RT) has a role in certain at-risk patients, although it is not recommended in low-risk PCa owing to the significant side-effects associated with RT and androgen deprivation therapy (ADT). The recommendations for salvage...
Journal Articles
An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment
Available to PurchaseSubject Area:
Further Areas
Wenhui Zhu, Hua Xu, Jing Ma, Jianming Guo, Wei Xue, Baojun Gu, Lu Sheng, Xudong Yao, Fukang Sun, Jian Gong, Weiliang Qiu, Qiang Ding, Haowen Jiang
Journal:
Urologia Internationalis
Urol Int (2017) 98 (1): 79–84.
Published Online: 30 September 2016
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate cancer Metformin Androgen deprivation therapy Insulin Body weight C-peptide...
Journal Articles
Prostate-Specific Antigen Kinetics under Androgen Deprivation Therapy and Prostate Cancer Prognosis
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2013) 91 (1): 38–48.
Published Online: 11 June 2013
... eligible patients with histologically confirmed and hormonally naïve prostate cancer, identified from the patients' database of Huashan Hospital, all received combined androgen deprivation therapy including bilateral orchiectomy or luteinizing hormone-releasing hormone antagonists with the oral...
Journal Articles
Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2013) 90 (1): 41–44.
Published Online: 11 December 2012
...C. Salvador; J. Planas; F. Agreda; J. Placer; E. Trilla; M.A. Lopez; J. Morote Objective: To analyse changes in lipid profiles observed in patients receiving androgen deprivation therapy (ADT) and to evaluate differences between medical castration and maximal androgen blockade (MAB). Material...
Journal Articles
Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer
Available to PurchaseSubject Area:
Further Areas
Rauf Taner Divrik, Levent Türkeri, Ali F. Şahin, Bülent Akdoğan, Ferhat Ateş, Çağ Çal, Sümer Baltacı, and Members of the Urooncology Association
Journal:
Urologia Internationalis
Urol Int (2012) 88 (1): 25–33.
Published Online: 17 December 2011
...) for primary advanced prostate cancer (PC) with bone metastasis. Methods: We evaluated all patients initially receiving androgen deprivation therapy (ADT) for primary advanced PC with bone metastasis. A total of 982 patients with complete medical records available for analysis from 18 centers were included...
Journal Articles
Optimal Duration of Androgen Deprivation in Combination with Radiation Therapy for Japanese Men with High-Risk Prostate Cancer
Available to PurchaseSubject Area:
Further Areas
Natsuki Takaha, Koji Okihara, Kazumi Kamoi, Yasunori Kimura, Takeshi Yamada, Akihiro Kawauchi, Kana Kobayashi, Hideya Yamazaki, Tsunehiko Nishimura, Tsuneharu Miki
Journal:
Urologia Internationalis
Urol Int (2011) 87 (1): 28–34.
Published Online: 23 June 2011
...Natsuki Takaha; Koji Okihara; Kazumi Kamoi; Yasunori Kimura; Takeshi Yamada; Akihiro Kawauchi; Kana Kobayashi; Hideya Yamazaki; Tsunehiko Nishimura; Tsuneharu Miki Objectives: To evaluate the efficacy and toxicity of external beam radiation therapy (EBRT) combined with androgen deprivation therapy...
Journal Articles
Getting Personal with Prostate Cancer: Adding New Pieces to an Incomplete Jigsaw Puzzle
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2011) 87 (2): 127–133.
Published Online: 30 April 2011
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Castration-resistant prostate cancer Androgen deprivation therapy Review Review Urol Int 2011;87:127 133 DOI: 10.1159...
Journal Articles
A Holistic Approach to Androgen Deprivation Therapy: Treating the Cancer without Hurting the Patient
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2009) 83 (4): 373–378.
Published Online: 08 December 2009
...Bertrand Tombal Introduction: Androgen deprivation therapy (ADT) for advanced prostate cancer can be associated with side effects which may negatively impact quality of life (QoL) and induce serious medical problems. Aim: The aim is to give practical recommendations on how to monitor and counsel...
Journal Articles
Percentage of Positive Biopsy Cores at the Onset of Hormone Therapy for Prostate Cancer: Prognostic Significance
Available to PurchaseSubject Area:
Further Areas
Guillaume Normand, Olivier Celhay, Raphaël Briffaux, Christophe Pirès, Bertrand Doré, Gaëlle Fromont, Jacques Irani
Journal:
Urologia Internationalis
Urol Int (2009) 83 (2): 160–165.
Published Online: 10 September 2009
... to hormonal independence and survival in prostate cancer patients treated with androgen deprivation therapy (ADT). Patients and Methods: We used clinical data from 403 men treated with ADT between 1980 and 1999 and focused on a subgroup of 220 patients treated with GnRH analogue. %PBC was defined...
Journal Articles
Diagnostic Accuracy of Percent Free Prostate-Specific Antigen in Prostatic Pathology and Its Usefulness in Monitoring Prostatic Cancer Patients
Available to PurchaseSubject Area:
Further Areas
Daniele Minardi, Andrea Benedetto Galosi, Alberto Recchioni, Lisy Giammarco, Mario Polito, Giovanni Muzzonigro
Journal:
Urologia Internationalis
Urol Int (2001) 67 (4): 272–282.
Published Online: 07 December 2001
... with prostatic cancer. Benign prostatic hypertrophy Prostatic inflammation Prostatic cancer Serum prostate-specific antigen Free prostate-specific antigen Percent free prostate-specific antigen Androgen deprivation therapy Original Paper Urol Int 2001;67:272 282 Received: July 4, 2000 Accepted after...